Page 182 - Vitamin D and Cancer
P. 182

7  Induction of Differentiation in Cancer Cells by Vitamin D    169

              101. Manggau M, Kim DS, Ruwisch L, Vogler R, Korting HC, Schafer-Korting M, Kleuser
               B (2001) 1alpha, 25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by
               the formation of sphingosine-1-phosphate. J Invest Dermatol 117:1241–1249
             102.  Lu J, Goldstein KM, Chen P, Huang S, Gelbert LM, Nagpal S (2005) Transcriptional profiling
               of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. J Invest
               Dermatol 124:778–785
             103.  Feinberg MW, Wara AK, Cao Z, Lebedeva MA, Rosenbauer F, Iwasaki H, Hirai H, Katz JP,
               Haspel RL, Gray S, Akashi K, Segre J, Kaestner KH, Tenen DG, Jain MK (2007) The Kruppel-
               like factor KLF4 is a critical regulator of monocyte differentiation. Embo J 26:4138–4148
              104. Autieri  MV  (2008)  Kruppel-like  factor  4:  transcriptional  regulator  of  proliferation,  or
               inflammation, or differentiation, or all three? Circ Res 102:1455–1457
              105. Alder JK, Georgantas RW 3rd, Hildreth RL, Kaplan IM, Morisot S, Yu X, McDevitt M,
               Civin CI (2008) Kruppel-like factor 4 is essential for inflammatory monocyte differentiation
               in vivo. J Immunol 180:5645–5652
              106. Dai X, Sayama K, Shirakata Y, Tokumaru S, Yang L, Tohyama M, Hirakawa S, Hanakawa Y,
               Hashimoto K (2008) PPAR gamma is an important transcription factor in 1 alpha, 25-dihy-
               droxyvitamin D3-induced involucrin expression. J Dermatol Sci 50:53–60
              107. Bikle DD, Pillai S, Gee E (1991) Squamous carcinoma cell lines produce 1, 25 dihydroxyvi-
               tamin D, but fail to respond to its prodifferentiating effect. J Invest Dermatol 97:435–441
              108. Solomon  C,  White  JH,  Kremer  R  (1999)  Mitogen-activated  protein  kinase  inhibits  1,
               25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid
               X receptor alpha. J Clin Invest 103:1729–1735
              109. McGuire  TF,  Trump  DL,  Johnson  CS  (2001)  Vitamin  D3-induced  apoptosis  of  murine
               squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and
               up-regulation of MEKK-1. J Biol Chem 276:26365–26373
              110. Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS (2006) Role of nongenomic activation of
               phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-
               regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-medi-
               ated apoptosis in squamous cell carcinoma cells. Cancer Res 66:8131–8138
              111. Xie Z, Bikle DD (1998) Differential regulation of vitamin D responsive elements in normal
               and transformed keratinocytes. J Invest Dermatol 110:730–733
              112. Goltzman D, White J, Kremer R (2001) Studies of the effects of 1, 25-dihydroxyvitamin D
               on  skeletal  and  calcium  homeostasis  and  on  inhibition  of  tumor  cell  growth.  J  Steroid
               Biochem Mol Biol 76:43–47
              113. Oda Y, Sihlbom C, Chalkley RJ, Huang L, Rachez C, Chang CP, Burlingame AL, Freedman
               LP, Bikle DD (2003) Two distinct coactivators, DRIP/mediator and SRC/p160, are differen-
               tially involved in vitamin D receptor transactivation during keratinocyte differentiation. Mol
               Endocrinol 17:2329–2339
              114. Tokuumi Y (1995) Correlation between the concentration of 1, 25 alpha dihydroxyvitamin
               D3 receptors and growth inhibition, and differentiation of human osteosarcoma cells induced
               by vitamin D3. Nippon Seikeigeka Gakkai Zasshi 69:181–190
              115. Van Auken M, Buckley D, Ray R, Holick MF, Baran DT (1996) Effects of the vitamin D3
               analog 1 alpha, 25-dihydroxyvitamin D3–3 beta-bromoacetate on rat osteosarcoma cells:
               comparison with 1 alpha, 25-dihydroxyvitamin D3. J Cell Biochem 63:302–310
             116.  Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995) Development and characterization of a
               conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178–86
              117. Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW,
               Manolagas SC (2005) Nongenotropic, anti-apoptotic signaling of 1alpha, 25(OH) -vitamin
                                                                        2
               D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts
               and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem
               280:14130–14137
             118.  Cordero JB, Cozzolino M, Lu Y, Vidal M, Slatopolsky E, Stahl PD, Barbieri MA, Dusso A
               (2002) 1, 25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-
               promoting signals by the epidermal growth factor receptor. J Biol Chem 277:38965–38971
   177   178   179   180   181   182   183   184   185   186   187